Trial Profile
The analysis of CTC in CRPC patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Jul 2017
Price :
$35
*
At a glance
- Drugs Abiraterone (Primary) ; Cabazitaxel (Primary) ; Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 29 Jun 2017 Status changed from not yet recruiting to recruiting.
- 17 May 2016 New trial record